Indications and uses
relieves occasional constipation (irregularity) generally produces bowel movement in 1/2 to 6 hours
relieves occasional constipation (irregularity) generally produces bowel movement in 1/2 to 6 hours
• shake well before use • do not exceed the maximum recommended daily dose in a 24 hour period • dose may be taken once a day preferably at bedtime, in divided doses, or as directed by a doctor • drink a full glass (8 oz) of liquid with each dose adults and children 12 years and older: 2 to 4 tablespoonfuls (TBSP) children 6 to 11 years: 1 to 2 tablespoonfuls (TBSP) children under 6 years: ask a doctor
• magnesium 500 mg • store at room temperature and avoid freezing • close cap tightly after use • each 15 mL tablespoonful contains: TAMPER-EVIDENT: Do not use if imprinted neckband is missing or broken.
Magnesium hydroxide 1200 mg
Saline laxative
Ask a doctor before use if you have
Ask a doctor or pharmacist before use if you are taking a prescription drug.
This product may interact with certain prescription drugs.
Stop use and ask a doctor if
If pregnant or breast-feeding, ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
Keep out of reach of children.
• shake well before use • do not exceed the maximum recommended daily dose in a 24 hour period • dose may be taken once a day preferably at bedtime, in divided doses, or as directed by a doctor • drink a full glass (8 oz) of liquid with each dose adults and children 12 years and older: 2 to 4 tablespoonfuls (TBSP) children 6 to 11 years: 1 to 2 tablespoonfuls (TBSP) children under 6 years: ask a doctor
• magnesium 500 mg • store at room temperature and avoid freezing • close cap tightly after use •
each 15 mL tablespoonful contains:
TAMPER-EVIDENT: Do not use if imprinted neckband is missing or broken.
purified water, sodium hypochlorite
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 253017 | magnesium hydroxide 1200 MG in 15 mL Oral Suspension | PSN | 11 |
| 253017 | magnesium hydroxide 80 MG/ML Oral Suspension | SCD | 11 |
| 253017 | magnesium hydroxide 1200 MG per 15 ML Oral Suspension | SY | 11 |
| 253017 | milk of magnesia 2400 MG per 30 ML Oral Suspension | SY | 11 |
| 253017 | milk of magnesia 400 MG per 5 ML Oral Suspension | SY | 11 |
| 253017 | milk of magnesia 8 % Oral Suspension | SY | 11 |
| 253017 | milk of magnesia 80 MG/ML Oral Suspension | SY | 11 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 17856-0788-1 | 2024-05-08 | C162847 | 48780-1 | f386c64a-0595-0266-e053-dadaa90a7c1a | 30fb7b5e-56a3-423e-ae57-432006b54fff |
| 17856-0788-3 | 2024-05-08 | C162847 | 48780-1 | f386c64a-0595-0266-e053-dadaa90a7c1a | 30fb7b5e-56a3-423e-ae57-432006b54fff |
| 17856-0788-1 | 2023-01-30 | C162847 | 48780-1 | f386c64a-0595-0266-e053-dadaa90a7c1a | 30fb7b5e-56a3-423e-ae57-432006b54fff |
| 17856-0788-3 | 2023-01-30 | C162847 | 48780-1 | f386c64a-0595-0266-e053-dadaa90a7c1a | 30fb7b5e-56a3-423e-ae57-432006b54fff |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0788-1 | MILK OF MAGNESIA ORIGINAL | 10 mL in 1 CUP | LIQUID | 10 | 11 | |
| 17856-0788-3 | MILK OF MAGNESIA ORIGINAL | 30 mL in 1 CUP | LIQUID | 30 | 11 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0788 | MILK OF MAGNESIA ORIGINAL (MAGNESIUM HYDROXIDE) LIQUID [ATLANTIC BIOLOGICALS CORP.] | 11 | Current NDC, Legacy NDC, 2 package rows | 20250524_30fb7b5e-56a3-423e-ae57-432006b54fff.zip |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0904-0788-14 | ML - Milliliter | 0904-0788 | 2ec21e5a-76da-4529-bf16-65931e967b29 | 1 | 2012-07-24 |
| 0904-0788-16 | ML - Milliliter | 0904-0788 | ffb3204a-7af4-4e4d-a6c6-2776e1356ce9 | 1 | 2012-07-24 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| MAGNESIUM HYDROXIDE | ACTIVE INGREDIENT | NBZ3QY004S | 7 | |
| MAGNESIUM CATION | ACTIVE MOIETY | T6V3LHY838 | 7 | |
| SODIUM HYPOCHLORITE | INACTIVE INGREDIENT | DY38VHM5OD | 7 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 7 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 17856-0788 | 17856-0788-1, 17856-0788-3 |
| 0904-0788 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| WATER | 059QF0KO0R | IACT |
| SODIUM HYPOCHLORITE | DY38VHM5OD | IACT |
| MAGNESIUM HYDROXIDE | NBZ3QY004S | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| SODIUM HYPOCHLORITE | SODIUM HYPOCHLORITE | DY38VHM5OD | SUSPENSION / ORAL | 3 mg/1ml | ||
| SODIUM HYPOCHLORITE | SODIUM HYPOCHLORITE | DY38VHM5OD | SUSPENSION / ORAL | 3 mg/1ml | ||
| SODIUM HYPOCHLORITE | SODIUM HYPOCHLORITE | DY38VHM5OD | SUSPENSION / ORAL | 3 mg/1ml | ||
| SODIUM HYPOCHLORITE | SODIUM HYPOCHLORITE | DY38VHM5OD | SUSPENSION / ORAL | 3 mg/1ml |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MILK OF MAGNESIA ORIGINAL | MAGNESIUM HYDROXIDE | MAJOR Pharmaceuticals Inc. | 673311f7-0b83-410c-a480-8e57d0190296 | 2025-12-11 | Warnings | 0904-0788 |
| MILK OF MAGNESIA ORIGINAL | MAGNESIUM HYDROXIDE | ATLANTIC BIOLOGICALS CORP. | 30fb7b5e-56a3-423e-ae57-432006b54fff | 2025-05-23 | Warnings | 17856-0788-1 17856-0788-3 17856-0788 17856078803 17856078801 35ced1e9-4623-5d8a-e063-6294a90a0142 30fb7b5e-56a3-423e-ae57-432006b54fff |
Adverse event summaries are temporarily unavailable. Other product information remains available.